biosimilars in oncology: addressing awareness
Published 4 years ago • 113 plays • Length 7:20Download video MP4
Download video MP3
Similar videos
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
3:21
biosimilars in oncology: future directions
-
7:21
biologic drugs and biosimilars
-
4:12
the basics of biosimilars
-
57:41
webinar: biologics & biosimilars
-
49:09
pinpointing the top questions and considerations about biosimilars in hematology/oncology
-
38:15
biosimilars and biologics
-
24:48
fda perspectives on biosimilar bla-manufacturing (28of33) quality – oct. 16-17, 2019
-
1:11:38
biologics at large | apfed eos support webinar series
-
8:07
biosimilars | what is a biosimilar? | gastrointestinal society
-
3:07
the promise of biosimilars
-
2:47
biosimilars: approval process
-
1:05:41
the international biosimilars experience - lessons for alberta - ihe biosimilars forum
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
59:39
biosimilars and their use in cancer treatment
-
4:53
the value and strategy for incorporating biosimilars into clinical practice
-
1:58
practical considerations for introducing biosimilars
-
5:56
the complexity of choosing biosimilars in oncology
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
5:58
the availability of multiple biosimilars for 1 biologic
-
5:00
determining biosimilars' role in the formulary
-
1:36
interchangeable biosimilars